Effect of vernolide-A, a sesquiterpene lactone from Vernonia cinerea L., on cell-mediated immune response in B16F-10 metastatic melanoma-bearing mice

References

• Fidler, I.J. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res. 1990, 50, 6130–6138.
   PubMed Web of Science ®Google Scholar
• Manesh, C., Kuttan, G. Effect of naturally occurring isothiocyanates on the immune system. Immunopharmacol. Immunotoxicol. 2003, 25, 451–459.
   PubMed Web of Science ®Google Scholar
• Burleson, G.R., Burleson, F.G., Dietert, R.R. The cytotoxic T lymphocyte assay for evaluating cell-mediated immune function. Methods Mol. Biol. 2010, 598, 195–205.
   PubMedGoogle Scholar
• Tsavaris, N., Kosmas, C., Vadiaka, M., Kanelopoulos, P., Boulamatsis, D. Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br. J. Cancer 2002, 87, 21–27.
   PubMed Web of Science ®Google Scholar
• Feghali, C., Wright, T. Cytokines in acute and chronic inflammation. Front. Biosci. 1997, 2.
   PubMedGoogle Scholar
• Arend, W.P., Gabay, C. Cytokines in the rheumatic diseases. Rheum. Dis. Clin. North Am. 2004, 30, 41–67, v.
   PubMed Web of Science ®Google Scholar
• Moretta, L., Bottino, C., Cantoni, C., Mingari, M.C., Moretta, A. Human natural killer cell function and receptors. Curr. Opin. Pharmacol. 2001, 1, 387–391.
   PubMedGoogle Scholar
• Claus, M., Watzl, C. Evaluation of human natural killer cell activities in whole blood. Curr. Protoc. Immunol. 2010, Chapter 7, Unit7 39.
   PubMedGoogle Scholar
• Vivier, E., Tomasello, E., Baratin, M., Walzer, T., Ugolini, S. Functions of natural killer cells. Nat. Immunol. 2008, 9, 503–510.
   PubMed Web of Science ®Google Scholar
• Barkas, T., AL-Khateeb, S.F., Irvine, W.J., Davidson, N.M., Roscoe, P. Inhibition of antibody-dependent cell-mediated cytotoxicity (ADCC) as a means of detection of immune complexes in the sera of patients with thyroid disorders and bronchogenic carcinoma. Clin. Exp. Immunol. 1976, 25, 270–279.
   PubMed Web of Science ®Google Scholar
• Timonen, T. Natural killer cells: endothelial interactions, migration, and target cell recognition. J. Leukoc. Biol. 1997, 62, 693–701.
   PubMed Web of Science ®Google Scholar
• Newman, D.J., Cragg, G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70, 461–477.
   PubMed Web of Science ®Google Scholar
• Zhang, S., Won, Y.K., Ong, C.N., Shen, H.M. Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms. Curr. Med. Chem. Anticancer. Agents 2005, 5, 239–249.
   PubMedGoogle Scholar
• Kumar, P.P., Kuttan, G. Vernonia cinerea L. scavenges free radicals and regulates nitric oxide and proinflammatory cytokines profile in carrageenan induced paw edema model. Immunopharmacol. Immunotoxicol. 2009, 31, 94–102.
   PubMed Web of Science ®Google Scholar
• Pratheeshkumar, P., Kuttan, G. Modulation of immune response by Vernonia cinerea L. inhibits the proinflammatory cytokine profile, iNOS, and COX-2 expression in LPS-stimulated macrophages. Immunopharmacol. Immunotoxicol. 2010, 2010 Apr 6. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Pratheeshkumar, P., Kuttan, G. Ameliorative action of Vernonia cinerea L. on cyclophosphamide-induced immunosuppression and oxidative stress in mice. Inflammopharmacology 2010, 18, 197–207.
   PubMedGoogle Scholar
• Pratheeshkumar, P., Kuttan, G. Protective role of Vernonia cinerea L. against gamma radiation-induced immunosupression and oxidative stress in mice. Hum. Exp. Toxicol. 2010.
   PubMed Web of Science ®Google Scholar
• Kuo, Y.H., Kuo, Y.J., Yu, A.S., Wu, M.D., Ong, C.W., Yang Kuo, L.M., Huang, J.T., Chen, C.F., Li, S.Y. Two novel sesquiterpene lactones, cytotoxic vernolide-A and -B, from Vernonia cinerea. Chem. Pharm. Bull. 2003, 51, 425–426.
   PubMed Web of Science ®Google Scholar
• Chea, A., Hout, S., Long, C., Marcourt, L., Faure, R., Azas, N., Elias, R. Antimalarial activity of sesquiterpene lactones from Vernonia cinerea. Chem. Pharm. Bull. 2006, 54, 1437–1439.
   PubMed Web of Science ®Google Scholar
• Chen, X., Zhan, Z.J., Yue, J.M. Sesquiterpenoids from Vernonia cinerea. Nat. Prod. Res. 2006, 20, 31–35.
   PubMed Web of Science ®Google Scholar
• Kim, Y.B., Huh, N.D., Koren, H.S., Amos, D.B. Natural killing (NK) and antibody-dependent cellular cytotoxicity (ADCC) in specific pathogen-free (SPF) miniature swine and germfree piglets. I. Comparison of NK and ADCC. J. Immunol. 1980, 125, 755–762.
   PubMed Web of Science ®Google Scholar
• Gupta, S., Bhattacharya, B. Cytotoxicity assays. In: A Handbook of Practical and Clinical Immunology. 2002, Cbs Publishers & Distributor, Delhi, Vol. 1, pp. 299–300.
   Google Scholar
• Mitchell, M.S. Immunotherapy as part of combinations for the treatment of cancer. Int. Immunopharmacol. 2003, 3, 1051–1059.
   PubMed Web of Science ®Google Scholar
• Ehrke, M.J. Immunomodulation in cancer therapeutics. Int. Immunopharmacol. 2003, 3, 1105–1119.
   PubMed Web of Science ®Google Scholar
• Fidler, I.J. Immunomodulation of macrophages for cancer and antiviral therapy, in Tomlinson, E and Davis, SS (eds): Site Specific Drug Delivery. New York, NY, Wiley, 1986, 111–134.
   Google Scholar
• Manu, K.A., Kuttan, G. Boerhaavia diffusa stimulates cell-mediated immune response by upregulating IL-2 and downregulating the pro-inflammatory cytokines and GM-CSF in B16F-10 metastatic melanoma bearing mice. J. Exp. Ther. Oncol. 2008, 7, 17–29.
   PubMedGoogle Scholar
• Guruvayoorappan, C., Kuttan, G. Effect of Biophytum sensitivum on cell-mediated immune response in mice. Immunopharmacol Immunotoxicol. 2007, 29, 337–350.
   Google Scholar
• Raphael, T.J., Kuttan, G. Effect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system. Phytomedicine 2003, 10, 483–489.
   PubMed Web of Science ®Google Scholar
• Manu, K.A., Kuttan, G. Effect of punarnavine, an alkaloid from Boerhaavia diffusa, on cell-mediated immune responses and TIMP-1 in B16F-10 metastatic melanoma-bearing mice. Immunopharmacol. Immunotoxicol. 2007, 29, 569–586.
   PubMed Web of Science ®Google Scholar
• Sunila, E.S., Kuttan, G. Immunomodulatory and antitumor activity of Piper longum Linn. and piperine. J. Ethnopharmacol. 2004, 90, 339–346.
   PubMed Web of Science ®Google Scholar
• Mathew, S., Kuttan, G. Immunomodulatory and antitumour activities of Tinospora cordifolia. Fitoterapia 1999, 70, 35–43.
   Web of Science ®Google Scholar
• Thejass, P., Kuttan, G. Modulation of cell-mediated immune response in B16F-10 melanoma-induced metastatic tumor-bearing C57BL/6 mice by sulforaphane. Immunopharmacol. Immunotoxicol. 2007, 29, 173–186.
   PubMed Web of Science ®Google Scholar
• Sheeja, K., Kuttan, G. Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice. Integr. Cancer Ther. 2007, 6, 66–73.
   PubMed Web of Science ®Google Scholar
• Ahmad, A., Menezes, J. Antibody-dependent cellular cytotoxicity in HIV infections. FASEB J. 1996, 10, 258–266.
   PubMed Web of Science ®Google Scholar
• Trinchieri, G. Biology of natural killer cells. Adv. Immunol. 1989, 47, 187–376.
   PubMed Web of Science ®Google Scholar
• Whiteside, T.L., Herberman, R.B. Role of human natural killer cells in health and disease. Clin. Diagn. Lab. Immunol. 1994, 1, 125–133.
   PubMedGoogle Scholar
• Moore, M. Natural immunity to tumours–theoretical predictions and biological observations. Br. J. Cancer 1985, 52, 147–151.
   PubMed Web of Science ®Google Scholar
• Tateno, K., Minamino, T., Toko, H., Akazawa, H., Shimizu, N., Takeda, S., Kunieda, T., Miyauchi, H., Oyama, T., Matsuura, K. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ. Res. 2006, 98, 1194–1202.
   PubMed Web of Science ®Google Scholar
• Tricot, G.J. New insights into role of microenvironment in multiple myeloma. Int. J. Hematol. 2002, 76 (Suppl 1), 334–336.
   PubMed Web of Science ®Google Scholar
• Takeda, K., Hatakeyama, K., Tsuchiya, Y., Rikiishi, H., Kumagai, K. A correlation between GM-CSF gene expression and metastases in murine tumors. Int. J. Cancer 1991, 47, 413–420.
   PubMed Web of Science ®Google Scholar
• Ognibene, F.P., Rosenberg, S.A., Lotze, M., Skibber, J., Parker, M.M., Shelhamer, J.H., Parrillo, J.E. Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock. Chest 1988, 94, 750–754.
   PubMed Web of Science ®Google Scholar
• Rosenberg, S.A., Yang, J.C., Topalian, S.L., Schwartzentruber, D.J., Weber, J.S., Parkinson, D.R., Seipp, C.A., Einhorn, J.H., White, D.E. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA 1994, 271, 907–913.
   PubMed Web of Science ®Google Scholar
• Djeu, J.Y., Heinbaugh, J.A., Holden, H.T., Herberman, R.B. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J. Immunol. 1979, 122, 175–181.
   PubMed Web of Science ®Google Scholar